International Journal of Radiation Oncology Biology Physics
International Journal of Radiation Oncology Biology Physics
5 years ago

STING-dependent interferon-λ1 induction in HT29 cells, a human colorectal cancer cell line following gamma-radiation

Ionizing radiation augments anti-tumor immune responses with interferons (IFN) acting as mediators. Of the three types of IFNs, type I and II IFNs are induced in irradiated tumors with induction of type III IFNs (IFNLs) currently not reported. Here, we investigated the induction of type III IFNs in human cancer cells by gamma-rays and its mechanisms. Methods and Materials Type III IFN expression in human cancer cell lines following gamma-ray irradiation in vitro was assessed by RT-qPCR and ELISA. Signaling pathways mediating type III IFN induction were examined by a variety of means, including immunoblotting, flow cytometry, confocal imaging and RT-qPCR. Key mediators in these pathways were further explored and validated using gene CRISPR knockout or shRNA knockdown. Results Exposure to gamma-rays directly induced type III IFNs (mainly IFNL1) in human cancer cell lines in dose- and time-dependent fashions. The induction of IFNL1 was primarily mediated by the cytosolic DNA sensors-STING-TBK1-IRF1 signaling axis with a lesser contribution from NF-κB signaling in HT29 cells. In addition, type III IFN signaling through its receptors serves as a positive feedback loop further enhancing IFN expression via upregulation of the kinases in the STING-TBK1 signaling axis. Conclusions Our results suggest that IFNL1 can be upregulated in human cancer cell lines following gamma-rays treatment. In HT29 cells this induction occurs via the STING pathway adding another layer of complexity to the understanding of radiation-induced anti-tumor immunity and may provide novel insights into IFN-based cancer treatment.

Publisher URL: www.sciencedirect.com/science

DOI: S0360301618302153

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.